Description

2-(2,7-Dimethyl-5,6,7,8-Tetrahydro-Benzo[4,5]-Thieno[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active pharmaceutical ingredients (APIs). This compound is valued for its role as a key building block in medicinal chemistry, enabling the development of targeted therapeutic agents. It is primarily required by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers focused on oncology, neurology, and other specialized drug discovery pipelines.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug candidates, particularly in kinase inhibitor research.
• Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Tool Compound: Serves as a reference standard or a starting material for developing biochemical probes to study specific biological pathways.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for exploratory research in heterocyclic and fused-ring chemistry.

Basic Information

Product Name	2-(2,7-Dimethyl-5,6,7,8-Tetrahydro-Benzo[4,5]-Thieno[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid
CAS No.	1008212-42-7
Molecular Formula	C17H21N3O2S
Molecular Weight	331.43 g/mol
Synonyms	2-[(2,7-Dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]propanoic acid; 2-(2,7-Dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-ylamino)propionic acid; Propanoic acid, 2-[(2,7-dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]-; CAS 1008212-42-7; Benzo[4,5]thieno[2,3-d]pyrimidine propionic acid derivative
EINECS	Contact for details

Quality Control

Our production of 2-(2,7-Dimethyl-5,6,7,8-Tetrahydro-Benzo[4,5]-Thieno[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid adheres to stringent quality protocols suitable for pharmaceutical R&D. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis. Certificates of Analysis (COA) detailing all specifications are provided to ensure traceability and support your regulatory and research requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent product degradation or clumping. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.